Chunfeng Sun - Publications

ASO Author Reflections: Beyond Whole-Tumor Analysis-Unveiling the Prognostic Power of PET Radiomic Habitats in Invasive Lung Adenocarcinoma.

Journal: Annals of surgical oncology

Published: November 28, 2025

Case Report: Glofitamab in the treatment of a patient with central nervous system-involved Burkitt lymphoma.

Journal: Frontiers in oncology

Published: October 13, 2025

Radioactive hydrogel with NETs degradation capacity for the boosted tumor radio-immunotherapy.

Journal: Materials today. Bio

Published: September 15, 2025

Explainable PET-Based Habitat Modeling for Predicting Postoperative Recurrence Risk in Invasive Lung Adenocarcinoma.

Journal: Annals of surgical oncology

Published: August 01, 2025

Novel PET imaging biomarkers as predictors of postoperative recurrence in lung adenocarcinoma.

Journal: BMC cancer

Published: February 18, 2025

A PET/CT-based 3D deep learning model for predicting spread through air spaces in stage I lung adenocarcinoma.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 12, 2024

Differential reinforcement of cGAS-STING pathway-involved immunotherapy by biomineralized bacterial outer membrane-sensitized EBRT and RNT.

Journal: Journal of nanobiotechnology

Published: February 24, 2024

Multi-regulatory potency of USP1 on inflammasome components promotes pyroptosis in thyroid follicular cells and contributes to the progression of Hashimoto's thyroiditis.

Journal: Molecular medicine (Cambridge, Mass.)

Published: February 12, 2024

A radiomics-boosted deep-learning for risk assessment of synchronous peritoneal metastasis in colorectal cancer.

Journal: Insights into imaging

Published: December 27, 2023

LncRNA ANRIL negatively regulated chitooligosaccharide-induced radiosensitivity in colon cancer cells by sponging miR-181a-5p.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: February 02, 2021

Lenalidomide combined with R-GDP in a patient with refractory CD5-positive diffuse large B-cell lymphoma: A promising response and review.

Journal: Cancer biology & therapy

Published: April 04, 2018